First Header Logo Second Header Logo

Connection

Giuseppe Orlando to Immunosuppression

This is a "connection" page, showing publications Giuseppe Orlando has written about Immunosuppression.
Connection Strength

2.706
  1. Stratta RJ, Farney AC, Rogers J, Orlando G. Immunosuppression for pancreas transplantation with an emphasis on antibody induction strategies: review and perspective. Expert Rev Clin Immunol. 2014 Jan; 10(1):117-32.
    View in: PubMed
    Score: 0.443
  2. Orlando G. Immunosuppression-free transplantation reconsidered from a regenerative medicine perspective. Expert Rev Clin Immunol. 2012 Feb; 8(2):179-87.
    View in: PubMed
    Score: 0.388
  3. Orlando G, Wood KJ, Soker S, Stratta RJ. How regenerative medicine may contribute to the achievement of an immunosuppression-free state. Transplantation. 2011 Oct 27; 92(8):e36-8; author reply e39.
    View in: PubMed
    Score: 0.381
  4. Orlando G. Finding the right time for weaning off immunosuppression in solid organ transplant recipients. Expert Rev Clin Immunol. 2010 Nov; 6(6):879-92.
    View in: PubMed
    Score: 0.355
  5. Orlando G, Manzia T, Baiocchi L, Sanchez-Fueyo A, Angelico M, Tisone G. The Tor Vergata weaning off immunosuppression protocol in stable HCV liver transplant patients: the updated follow up at 78 months. Transpl Immunol. 2008 Nov; 20(1-2):43-7.
    View in: PubMed
    Score: 0.306
  6. Massart A, Pallier A, Pascual J, Viklicky O, Budde K, Spasovski G, Klinger M, Sever MS, Sørensen SS, Hadaya K, Oberbauer R, Dudley C, De Fijter JW, Yussim A, Hazzan M, Wekerle T, Berglund D, De Biase C, Pérez-Sáez MJ, Mühlfeld A, Orlando G, Clemente K, Lai Q, Pisani F, Kandus A, Baas M, Bemelman F, Ponikvar JB, Mazouz H, Stratta P, Subra JF, Villemain F, Hoitsma A, Braun L, Cantarell MC, Colak H, Courtney A, Frasca GM, Howse M, Naesens M, Reischig T, Serón D, Seyahi N, Tugmen C, Alonso Hernandez A, Bena L, Biancone L, Cuna V, Díaz-Corte C, Dufay A, Gaasbeek A, Garnier A, Gatault P, Gentil Govantes MA, Glowacki F, Gross O, Hurault de Ligny B, Huynh-Do U, Janbon B, Jiménez Del Cerro LA, Keller F, La Manna G, Lauzurica R, Le Monies De Sagazan H, Thaiss F, Legendre C, Martin S, Moal MC, Noël C, Pillebout E, Piredda GB, Puga AR, Sulowicz W, Tuglular S, Prokopova M, Chesneau M, Le Moine A, Guérif P, Soulillou JP, Abramowicz M, Giral M, Racapé J, Maggiore U, Brouard S, Abramowicz D. The DESCARTES-Nantes survey of kidney transplant recipients displaying clinical operational tolerance identifies 35 new tolerant patients and 34 almost tolerant patients. Nephrol Dial Transplant. 2016 06; 31(6):1002-13.
    View in: PubMed
    Score: 0.127
  7. Lerut JP, Pinheiro RS, Lai Q, Stouffs V, Orlando G, Juri JM, Ciccarelli O, Sempoux C, Roggen FM, De Reyck C, Latinne D, Gianello P. Is minimal, [almost] steroid-free immunosuppression a safe approach in adult liver transplantation? Long-term outcome of a prospective, double blind, placebo-controlled, randomized, investigator-driven study. Ann Surg. 2014 Nov; 260(5):886-91; discussion 891-2.
    View in: PubMed
    Score: 0.117
  8. Orlando G, Soker S, Stratta RJ. Organ bioengineering and regeneration as the new Holy Grail for organ transplantation. Ann Surg. 2013 Aug; 258(2):221-32.
    View in: PubMed
    Score: 0.108
  9. Orlando G, Soker S, Stratta RJ, Atala A. Will regenerative medicine replace transplantation? Cold Spring Harb Perspect Med. 2013 Aug 01; 3(8).
    View in: PubMed
    Score: 0.108
  10. Manzia TM, Angelico R, Baiocchi L, Toti L, Ciano P, Palmieri G, Angelico M, Orlando G, Tisone G. The Tor Vergata weaning of immunosuppression protocols in stable hepatitis C virus liver transplant patients: the 10-year follow-up. Transpl Int. 2013 Mar; 26(3):259-66.
    View in: PubMed
    Score: 0.103
  11. Orlando G, Hematti P, Stratta RJ, Burke GW, Di Cocco P, Cocco PD, Pisani F, Soker S, Wood K. Clinical operational tolerance after renal transplantation: current status and future challenges. Ann Surg. 2010 Dec; 252(6):915-28.
    View in: PubMed
    Score: 0.089
  12. Tisone G, Orlando G, Angelico M. Operational tolerance in clinical liver transplantation: emerging developments. Transpl Immunol. 2007 Feb; 17(2):108-13.
    View in: PubMed
    Score: 0.067
  13. Tisone G, Orlando G, Cardillo A, Palmieri G, Manzia TM, Baiocchi L, Lionetti R, Anselmo A, Toti L, Angelico M. Complete weaning off immunosuppression in HCV liver transplant recipients is feasible and favourably impacts on the progression of disease recurrence. J Hepatol. 2006 Apr; 44(4):702-9.
    View in: PubMed
    Score: 0.064
  14. Totonelli G, Maghsoudlou P, Fishman JM, Orlando G, Ansari T, Sibbons P, Birchall MA, Pierro A, Eaton S, De Coppi P. Esophageal tissue engineering: a new approach for esophageal replacement. World J Gastroenterol. 2012 Dec 21; 18(47):6900-7.
    View in: PubMed
    Score: 0.026
  15. Pareta R, Sanders B, Babbar P, Soker T, Booth C, McQuilling J, Sivanandane S, Stratta RJ, Orlando G, Opara EC. Immunoisolation: where regenerative medicine meets solid organ transplantation. Expert Rev Clin Immunol. 2012 Sep; 8(7):685-92.
    View in: PubMed
    Score: 0.025
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.